Skip to content
Use case 102

Healthcare AI Decision-Support Runtimes

A deployment concept for hospitals, medical software vendors, clinicians and health regulators.

Deployment concept · Suitability unverified
Artificial Intelligence and Data Systems

Why this environment matters

Modern healthcare AI decision-support runtimes depend on complex software, external data and remote administration. Here, the system runs models that assist clinicians with diagnosis, triage, risk scoring or treatment planning. If trust is misplaced, tampered models, hidden data leakage or an untrusted plugin can produce unsafe recommendations or expose health information. NØNOS could narrow the trusted computing base and give each function only the resources required for its defined job.

The security challenge

The threat model should assume that one component will eventually fail or be exploited. In this case, tampered models, hidden data leakage or an untrusted plugin can produce unsafe recommendations or expose health information. AI systems connect large datasets, opaque models, external prompts and increasingly powerful tools. A model should not inherit the full authority of the host merely because it was invited to answer a request. The aim is to prevent that single failure from automatically gaining the keys, devices, records and network paths of the whole platform.

How the capsule model could help

A candidate NØNOS architecture would attest approved model versions, isolate patient context and external tools, and prevent the AI process from silently writing clinical orders. The design would prioritise model and tool isolation and attested model loading, supported by ephemeral agent sessions and verifiable execution evidence. Each capsule would carry a declared policy for files, networks, devices and secrets, and unknown or altered software would not receive the same authority as an approved component.

Separate address spaces and capability checks can limit cross-process reach. They cannot stop harmful use of legitimate permissions, prove AI decisions correct or substitute for domain-specific safety controls.

Deployment requirements

Operating-system isolation cannot prove that a model is accurate, fair or safe. Model evaluation, human governance, data quality, monitoring and domain-specific controls remain necessary.

Current public-beta limitations, hardware support and application availability must be assessed before any pilot. Neither this use case nor an industry source establishes NONOS certification or a current customer deployment.

Who could buy or integrate it?

  • Hospital digital-health teams procuring clinical AI platforms with infrastructure
  • Medical AI vendors integrating model runtimes into supported clinical systems
  • Healthcare IT integrators deploying decision support within hospital data environments

Industry examples: Aidoc, Viz.ai. These are research prospects, not represented as NONOS customers, partners or endorsers.

Opportunity research

Separate the market from the model.

Published industry benchmark
US$36.7 billion

Artificial intelligence in healthcare

Global · 2025 · annual market estimate

Healthcare AI hardware, software and services spanning clinical, administrative, research and other applications; broader than decision-support runtimes.

Modelled global devices
10K–500K

Candidate OS endpoints

Hypothetical planning range · 2025

Low, hypothetical planning assumptions. Hardware eligibility, procurement and adoption remain unverified.

Illustrative annual licensing
$1M–$225M

USD / year at full model coverage

Device scenario × assumed US$100–$450 per device / year.

Not a revenue forecast, announced price or measured serviceable market.

Device calculation

Hypothetical global planning range, 2025 scenario: assume 10,000–100,000 hospitals and healthcare groups operating local decision-support AI × 1–5 candidate OS endpoints per site/asset = 10,000–500,000 endpoints. Counting unit: dedicated inference/gateway hosts; excludes ordinary clinical terminals. Site/asset counts and endpoint densities are author assumptions, not a measured installed base. Coverage is limited to the defined equipped subset; includes all candidate endpoints within that assumed subset. Hardware eligibility, certification, adoption and achievable NØNOS share are unverified; overlaps other cases.

Artificial intelligence in healthcare market report ↗

Context only, inherited market research; not a device/site denominator. Original monetary-market scope and geography are preserved in benchmark. This source does not establish the assumed worldwide site count or endpoint density.

How to interpret the figures

Adjacent or broader commercial market benchmark; not the NØNOS OS market, licensable-device count or revenue forecast.

Modelled candidate endpoints × assumed annual USD per-endpoint price. Price is an author assumption, not a vendor quote. Full-range mathematical scenario only: not a revenue forecast or TAM; excludes adoption timing, procurement, certification, support costs, channel economics and attainable market share. Case totals overlap and must not be added.

Inherited research compiled 13 Sep 2026; publisher estimates, not independently audited.

Read the full methodology

Explore NONOS

Choose your
NONOS experience.

Discover the platform for your organisation or explore the software.

You can reopen this chooser from the footer at any time.